Adjuvant Capital
Venture CapitalSwitzerland+ United States
Adjuvant Capital is a Series A/Series B/Series C investor in Switzerland. Focus: MedTech, Life Sciences. Ticket: $10M–$25M.
Min Ticket
$10M
Max Ticket
$25M
Stages
3 stages
Sectors
2 sectors
Investment Sectors
Details
- Headquarters
- Zurich, Switzerland
- Other Locations
- United States
- Min Ticket
- $10M
- Max Ticket
- $25M
- Reported Size
- $10-$25 million
- General Email
- yanatos@adjuvantcapital.com
View Portfolio
See companies Adjuvant Capital has invested in
